Wellfully (ASX:WFLOA) Total Receivables: A$0.83 Mil (As of Dec. 2023)


What is Wellfully Total Receivables?

Wellfully ASX:WFLOA Total Receivables is A$0.83 Mil as of Dec. 2023. The stock has 7 warning signs investors should review.

Wellfully's Total Receivables for the quarter that ended in Dec. 2023 was A$0.83 Mil.

Wellfully Total Receivables Historical Data

* Premium members only.

The historical data trend for Wellfully's Total Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Wellfully Total Receivables Chart

Wellfully Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Total Receivables
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.52 0.20 0.12 0.48 0.86

Wellfully Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Total Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.46 0.48 0.85 0.86 0.83

Wellfully Total Receivables Calculation

Total Receivables is the sum of all receivables owed by customers and affiliates within one year, including:
Accounts Receivable
Notes Receivable
Loans Receivable
Other Current Receivables

Frequently Asked Questions Learn more about Total Receivables →
What does a Total Receivables of A$0.83 Mil mean?
Wellfully (ASX:WFLOA) has a Total Receivables of A$0.83 Mil as of Dec. 2023. Total Receivables is the sum of all receivables owed by customers and affiliates within one year. View historical data on Wellfully and its competitors.
Is Wellfully's Total Receivables too high?
Wellfully's current Total Receivables is A$0.83 Mil.
How does Wellfully's Total Receivables compare to TMO and DHR?
Wellfully's Total Receivables of A$0.83 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Receivables for a Medical Diagnostics & Research company?
A good Total Receivables depends on the Medical Diagnostics & Research industry context. However, Total Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Receivables mean?
A high Total Receivables can signal that a stock is expensive relative to its fundamentals. Total Receivables is the sum of all receivables owed by customers and affiliates within one year. View historical data on Wellfully and its competitors. Wellfully's current Total Receivables is A$0.83 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Wellfully stock overvalued right now?
Wellfully (ASX:WFLOA) has a current Total Receivables of A$0.83 Mil. The current Total Receivables is A$0.83 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Receivables calculated?
Total Receivables is calculated from a company's financial statements. For Wellfully (ASX:WFLOA), the current Total Receivables is A$0.83 Mil as of Dec. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Wellfully Business Description

Address 284 Oxford Street, Ground Floor, Leederville, WA, AUS, 6007
Wellfully Ltd is engaged in the research and development of Dermaportation and ETP transdermal drug delivery technologies. The company operates in segments namely the development of the dermaportation drug delivery technology and Devices segments. Geographically, it derives a majority of its revenue from Europe and also has a presence in Japan. It serves the Pharmaceutical; Cosmetics Skincare and Consumer Healthcare industries.